A cure for cancer
An estimated 166,400 new cases of cancer and 73,800 deaths will occur in Canada in 2008. Based on current incidence rates, 40% of Canadian women will develop cancer during their lifetime. Among men, 45% will develop cancer during their lifetime.
Created in 1998, the Atlantic Cancer Research Institute’s (ACRI) works toward both the emergence of scientific breakthroughs that will help fight cancer and the modernization of patient care and facilities. Given its unique expertise, the ACRI has become a centre of excellence in the Atlantic Provinces and New Brunswick’s only hospital-based biomedical research centre.
ACRI researchers orient the majority of their research in projects related to early detection, elaborate diagnostics and targeted cancer treatments. Genomics, the study of genes located in human chromosomes, is the Institute’s research cornerstone because it allows deciphering and understanding of all the genetic information contained in an organism. The ACRI’s objective is straightforward: to understand how cancer works and to find solutions that increase the chance of survival of those who develop cancer.
The ACRI’s research team is comprised of approximately 30 scientists who favour a multidisciplinary research approach. The Institute also relies on the extremely valuable expertise of external partners from different universities and Canadian research centres.
On the eve of a new decade of research, ACRI will increase its number of research projects. In fact, the Institute plans more investments in state-of-the-art research facilities and maintains its efforts to attract the best and brightest research professionals.
All these efforts mean that cancer patients will be the first to benefit because their chances of survival will increase accordingly.
For additional information:
 Canadian Cancer Statistics produced by Canadian Cancer Society, National Cancer Institute of Canada, Statistics Canada, Provincial/Territorial Cancer Registries and Public Health Agency Canada